Noonan syndrome associated with Moyamoya disease: Report of one case

Acta Paediatrica Taiwanica

Volumn 40, Issue 4, 1999, Pages 274-276

  Tang, Kuo Ting ^a   Yang, Winnie ^a   Wong, Josephine ^a   Lee, Kei Yee ^a  

^a Section of Infectious Diseases   (Taiwan)

Author keywords

Flunarizine; Ischemic attack; Moyamoya; Noonan syndrome

Indexed keywords

FLUNARIZINE;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MOYAMOYA DISEASE; NOONAN SYNDROME; TRANSIENT ISCHEMIC ATTACK;

CHILD, PRESCHOOL; FEMALE; HUMANS; MOYAMOYA DISEASE; NOONAN SYNDROME;

EID: 0032717514     PISSN: 00016578     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Noonan JA, Ehmke DA. Associated non cardiac malformation in children with congenital heart disease. J Pediatr 1963; 63 468-70.
2. Noonan JA. Hypertelorism with Turner phenotype. Am J Dis Child 1968; 116:373-80.
3. Nora JJ, Nora AH, Shinha AK, Spangler RD, Lubs HA. The Ullrich-Noonan Syndrome (Turner phenotype). Am J Dis Child 1974; 127:48-55.
4. Ganesan V, Kirkham FJ. Noonan syndrome and moyamoya. Pediatr Neurol 1997; 16:256-8.
5. Houkin K, Tanaka N, Takahashi A, Kamimyama H, Abe H, Kajii N. Familial occurrence of moyamoya disease. Magnetic resonance angiography as screening test for high-risk subjects. Child Nerv Syst 1994; 10:421-5.
6. Yamada I, Mastsushima Y, Suzuki S. Moyamoya disease: Diagnosis with three-dimensional time-of-flight MR angiography. Radiology 1992; 184:773-8.
7. Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol 1997; 47:138-43.
8. Matsushima Y, Aoyagi M, Niimi Y, et al. Symptoms and their pattern of progression in childhood moyamoya disease. Brain Dev 1990; 6:784-9.
9. Kurokawa T, Tommita S, Ueda K, et al. Prognosis of occlusive disease of circle of Willis (moyamoya disease). Pediatr Neurol 1985; 5:274-7.
10. Suzuki J, Kodama N. Moyamoya disease - A review. Stroke 1983; 14:104-9.
11. Joel L, Michael S, Ruth N, Tal G. Moyamoya syndrome associated with congenital heart disease. Pediatrics 1998; 101:57-60.
12. Colvin EV. Cardiovascular embryology. In: Oski FA, DeAngelis CD, Feigin RD, Warshaw JB, eds. Principles and practice of pediatrics. Philadelphia: J.B. Lippincott, 1990; 1387-94.
13. Fukuyama Y, Kuriya Y, Imezu R An experience of neurocoticosteroid hormone in childhood occlusion of circle of Willis, in Japanese, in Annual Report of special Working Group of Welfare Ministry of Moyamoya disease in Fiscal Year 1980. 1981; 45-51.
14. Suzuki J, Takaku A, Kodama N, Sato S. An attempt to treat cerebrovascular " moyamoya disease " in children. Child's Brain 1975; 1:193-206.
15. Spitther JF, Smektala K Pharmacotherapy in moyamoya disease. Hokkaido J Med Sic 1990; 2:235-40.
16. Kuroki M, Naganachi S, Hoshi H, et al. Cerebral perfusion imaging evaluates pharmacologic treatment of unilateral moyamoya disease. J Nucl Med 1996; 37:84-6.
17. Nakano M, Suzuki T, ShimadaH, et al. The efficacy of the flunarizine in the treatment of the ischemic attack of moyamoya disase. No to Hattatsu 1988; 20:252-4.
18. Haldovee J, De Clerck F. Protection by flunarizine against endothelial cell injury in vivo. Angiology 1981; 32:418-62.
19. De Cree J, De Cock W, et al. The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions. Angiography 1979; 30:505-15.
20. DeClerk F, De Cree J, Brugmans J, et al. Reduction by flunarizine of the increase of blood viscosity after is-chemic forearm occlusion. Arch Int Pharmacody 1977; 230:321-3.
21. Schon F, Bowler J, Baraitser M. Cerebral arteriovenous malformation in Noonan's syndrome. Postgrad Med J 1992; 68:37-40.
22. McAnena O, Buckley T, Padilla JR. Intracranial aneurysm in association with Noonan's syndrome. Ir Med J 1984; 77:140-1.
23. Hinnant CA. Noonan syndrome associated with thromboembolic brain infarcts and posterior circulation abnormalities. Am J Med Genet 1995; 56:241-4.